Questionable Validity of Peptide-Based ELISA Strategies in the Diagnostics of Cardiopathogenic Autoantibodies That Activate G-Protein-Coupled Receptors.
Comprehensive Heart Failure Center and Interdisciplinary Bank of Biomaterials and Data Würzburg, University Hospital of Würzburg, Würzburg, Germany.
Roland
R
Jahns
Fritz
F
Boege
D001323:Autoantibodies / Q000276:immunology*; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000276:immunology*; D017379:Hypertrophy, Left Ventricular / Q000276:immunology*; D008297:Male; D044140:Receptor, Angiotensin, Type 1 / Q000276:immunology*; D018342:Receptors, Adrenergic, beta-1 / Q000276:immunology*
D001323:Autoantibodies; D044140:Receptor, Angiotensin, Type 1; D018342:Receptors, Adrenergic, beta-1